Wang F - Search Results

1

A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer.

Zheng X, Xu Z, Ji Q, Ge M, Shi F, Qin J, Wang F, Chen G, Zhang Y, Huang R, Tan J, Huang T, Li S, Lv Z, Lin Y, Guo Z, Kubota T, Suzuki T, Ikezawa H, Gao M. Zheng X, et al. Among authors: wang f. Clin Cancer Res. 2021 Oct 15;27(20):5502-5509. doi: 10.1158/1078-0432.CCR-21-0761. Epub 2021 Jul 29. Clin Cancer Res. 2021. PMID: 34326132 Free PMC article. Clinical Trial.

2

Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Peng Z, Wei J, Wang F, Ying J, Deng Y, Gu K, Cheng Y, Yuan X, Xiao J, Tai Y, Wang L, Zou J, Zhang Y, Shen L. Peng Z, et al. Among authors: wang f, wang l. Clin Cancer Res. 2021 Jun 1;27(11):3069-3078. doi: 10.1158/1078-0432.CCR-20-4691. Epub 2021 Mar 25. Clin Cancer Res. 2021. PMID: 33766817 Clinical Trial.

3

Overexpression of microRNA‑125a‑3p effectively inhibits the cell growth and invasion of lung cancer cells by regulating the mouse double minute 2 homolog/p53 signaling pathway.

Li S, Li X, Zhao H, Gao M, Wang F, Li W. Li S, et al. Among authors: wang f. Mol Med Rep. 2015 Oct;12(4):5482-6. doi: 10.3892/mmr.2015.4038. Epub 2015 Jul 3. Mol Med Rep. 2015. PMID: 26151241

4

Trastuzumab plus docetaxel and capecitabine as a first-line treatment for HER2-positive advanced gastric or gastroesophageal junction cancer: a phase II, multicenter, open-label, single-arm study.

Wang F, Liu TS, Yuan XL, Luo HY, Gu KS, Yuan Y, Deng YH, Xu JM, Bai YX, Wang Y, Liao WJ, Zhang HL, Bi F, Wang BM, Zhuang ZX, Jiang TJ, Xu RH. Wang F, et al. Among authors: wang bm, wang y. Am J Cancer Res. 2020 Sep 1;10(9):3037-3046. eCollection 2020. Am J Cancer Res. 2020. PMID: 33042632 Free PMC article.

5

m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer.

Zhao H, Xu Y, Xie Y, Zhang L, Gao M, Li S, Wang F. Zhao H, et al. Among authors: wang f. Front Cell Dev Biol. 2021 Mar 4;9:650023. doi: 10.3389/fcell.2021.650023. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33748145 Free PMC article.

6

Prognosis of surgery combined with different adjuvant therapies in esophageal cancer treatment: a network meta-analysis.

Li S, Liu H, Diao C, Wang X, Gao M, Li Z, Song L, Gao X, Han J, Wang F, Li W, Han X. Li S, et al. Among authors: wang x, wang f. Oncotarget. 2017 May 30;8(22):36339-36353. doi: 10.18632/oncotarget.16193. Oncotarget. 2017. PMID: 28423740 Free PMC article.

7

Anti-PD-1 antibody SHR-1210 plus apatinib for metastatic colorectal cancer: a prospective, single-arm, open-label, phase II trial.

Ren C, Mai ZJ, Jin Y, He MM, Wang ZQ, Luo HY, Zhang DS, Wu CY, Wang F, Xu RH. Ren C, et al. Among authors: wang f, wang zq. Am J Cancer Res. 2020 Sep 1;10(9):2946-2954. eCollection 2020. Am J Cancer Res. 2020. PMID: 33042628 Free PMC article.

8

Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel in untreated patients with metastatic gastric cancer.

He MM, Wang F, Jin Y, Yuan SQ, Ren C, Luo HY, Wang ZQ, Qiu MZ, Wang ZX, Zeng ZL, Li YH, Wang FH, Zhang DS, Xu RH. He MM, et al. Among authors: wang f, wang zx, wang fh, wang zq. Cancer Sci. 2018 Nov;109(11):3575-3582. doi: 10.1111/cas.13813. Epub 2018 Oct 26. Cancer Sci. 2018. PMID: 30281875 Free PMC article. Clinical Trial.

9

SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy.

Wang F, Xia X, Yang C, Shen J, Mai J, Kim HC, Kirui D, Kang Y, Fleming JB, Koay EJ, Mitra S, Ferrari M, Shen H. Wang F, et al. Clin Cancer Res. 2018 Jul 1;24(13):3176-3185. doi: 10.1158/1078-0432.CCR-17-3435. Epub 2018 Mar 30. Clin Cancer Res. 2018. PMID: 29602802 Free PMC article.

10

Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer.

Zhang DS, Wang DS, Wang ZQ, Wang FH, Luo HY, Qiu MZ, Wang F, Li YH, Xu RH. Zhang DS, et al. Among authors: wang f, wang ds, wang fh, wang zq. Cancer Chemother Pharmacol. 2013 Apr;71(4):1065-72. doi: 10.1007/s00280-013-2102-4. Epub 2013 Mar 13. Cancer Chemother Pharmacol. 2013. PMID: 23483298 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46,364 results

Search Page